Haldar, Partha
Tripathi, Manjari
Prasad, Kameshwar
Kant, Shashi
Dwivedi, Sada Nand
Vibha, Deepti
Pandit, Awadh Kishor
Srivastava, Achal Kumar
Kumar, Amit
Ikram, MArfan
Henning, Tiemeier
Funding for this research was provided by:
Rajiv Gandhi Centre for Biotechnology, Department of Biotechnology, Ministry of Science and Technology, India (BT/IN/Netherland/03/KP/2012 dated 14/02/2014)
Department of Health Research, Ministry of Health and Family Welfare, Government of India (R.11012/15/2018-HR, dated 09/08/2018)
Department of Epidemiology, Erasmus University Medical Centre, the Netherlands
Alzheimer Nederland (WE.15–2014-09)
Article History
Received: 4 September 2023
Revised: 28 October 2023
Accepted: 20 November 2023
First Online: 6 December 2023
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the Institutional Ethics Committee of All India Institute of Medical Sciences, New Delhi, India (reference number: IEC/NP-53/2014 RP-12/2014), and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The LoCARPoN study was approved by the Institutional Ethics Committee of All India Institute of Medical Sciences, New Delhi, India (reference number: IEC/NP-53/2014 RP-12/2014).
: Informed consent was obtained from all individual participants included in the study.
: The authors declare no competing interests.